Syphilis: Guideline of the German STD Society for diagnosis and treatment of syphilis;Syphilis: Leitlinie der Deutschen STD gesellschaft zur diagnostik und therapie der syphilis

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 2, 2006, Pages 160-177

  Schöfer, Helmut ^a   Brockmeyer, Norbert H ^b   Hagedorn, Hans Jochen ^b   Hamouda, Osamah ^b   Handrick, Werner ^b   Krause, Walter ^b   Marcus, Ulrich ^b   Münstermann, Dieter ^b   Petry, Karl Ulrich ^b   Prange, Hilmar ^b   Potthoff, Anja ^b   Gross, Gerd ^b  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; HUMAN; INFECTION PREVENTION; LABORATORY TEST; MICROSCOPY; NEUROSYPHILIS; PATHOGENESIS; PATHOLOGY; REVIEW; SEROLOGY; SYPHILIS; TREATMENT PLANNING; TREPONEMA PALLIDUM;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CROSS-SECTIONAL STUDIES; DISEASE NOTIFICATION; EVIDENCE-BASED MEDICINE; FEMALE; GERMANY; HUMANS; INFANT, NEWBORN; MALE; NEUROSYPHILIS; PENICILLINS; PREGNANCY; SYPHILIS; SYPHILIS SERODIAGNOSIS; SYPHILIS, CONGENITAL; SYPHILIS, CUTANEOUS;

EID: 33645236068     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05857.x     Document Type: Review

References (98)

1. Ali L, Roos KL. Antibacterial therapy of neurosyphilis, lack of impact of new therapies. CNS Drugs 2002; 16: 799-802.
2. Azimi PH, et al. Concentrations of procaine and aqueous penicillin in the cerebrospinal fluid of infants treated for congenital syphilis. J Pediatr 1994; 124: 649-653.
3. Backhouse JL, Nesteroff SI. Treponema pallidum western blot: comparison with the FTA-ABS test as a confirmatory test for syphilis. Diagn Microbiol Inf Dis 2001; 39: 9-14.
4. Beck-Sague C, Alexander ER. Failure of benzathine penicillin G treatment in early congenital Pediatr Infect Dis J 1987; 6: 1061-1064.
5. Beeram MR, Chopade N, Dawood Y, Siriboe St, Abedin M. Lumbar puncture in the evaluation of possible asymptomatic congenital syphilis in neonates. J Pediatr 1996; 128: 125-129.
6. Berry CD, Hooton TM, Collier A, Lukehart S. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987; 316: 1587-1589.
7. Bracero L, Wormser GP, Bottone EJ. Serologic tests for syphilis: a guide to interpretation in various states of disaese. Mt Sinai J Med 1979; 46: 289-292.
8. Brandon WR, Boulos LM, Morse A. Determining the prevalence of neurosyphilis in a cohort co-infected with HIV. Int J STD AIDS 1993; 4: 99-101.
9. Brockmeyer NH Syphilis. In: Petzoldt D, Gross G (Hrsg.) Diagnostik und Therapie sexuell übertragbarer Krankheiten. Leitlinien 2001 der Deutschen STD-Gesellschaft. Springer Verlag Berlin, Heidelberg, New York S. 2001; 101-111.
10. Brown ST, Zaidi A, Larsen SA, Reynolds GH. Serological response to syphilis treatment. A new analysis of old data. JAMA 1985; 253: 1296-1299.
11. Bundesgesundheitsamt. Richtlinien 1979 für die Serodiagnose der Syphilis. Bundesgesundheitsbl 1979; 22: 398-400.
12. Burke JM, Schaberg DR. Neurosyphilis in the antibiotic era. Neurology 1985; 35: 1368-1371.
13. Carey, J. Congenital syphilis in the 21st century. Curr Womens Health Rep 2003; 3: 299-302.
14. Centers for Disease Control and Prevention. Azithromycin treatment failures in syphilis infections- San Francisco, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2004; 53: 197-198.
15. Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted disease. MMWR Morb Mortal Wkly Rep 1998; 47: 1-111.
16. Centers for Disease Control and prevention. Sexually transmitted disease treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51 (RR-6): 1-78.
17. Chisholm CA, Katz VL, McDonald TL, Bowes WA Jr. Penicillin desensitization in the treatment of syphilis during pregnancy. Am J Perinatol 1997; 14: 553-554.
18. Clark EG, Danbolt N. The Oslo study of the natural history of untreated syphilis. An epidemiologic investigation based on a restuda of the Boeck-Brunsgaard material. J Chronic Dis 1955; 2: 311-344.
19. Clinical Effectiveness Group; Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases. National guideline for the management of late syphilis. Sex Transm Infec 1999; 75(Suppl): S34-S37.
20. Czelusta A, Yen Moore A, van der Straaten M, Carrasco D, Tyring SK. An overview of sexually transmitted diseases Part 3. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 2000; 3: 409-432.
21. Dilley JW, Klausner JD, Mc Farland W, Kellogg TA, Kohn R, Wong W, Louie BT, Taylor MM, Kerndt PR, Carlos J, Chavers CR, Bolan G, Holmberg SD Greenberg AE, Byers RH, Buchacz KA, Patel P, King JB. Trends in primary and secondary syphilis and HIV infections in men who have sex wiht men- San Francisco and Los Angeles, California 2004; 1998-2002.
22. Dorfman DH, Glaser JH. Congenital syphilis presenting in infants after the newborn period. N Engl J Med 323: 1990; 1299-1302.
23. Dowell ME, Ross PG, Musher DM et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992; 93: 481-488.
24. Ducas J, Robson HG. Cerebrospinal fluid penicillin levels during therapy for latent syphilis. JAMA 1981; 246: 2583-2584.
25. Fonseca E, Garcia-Silva J, del Pozo J, Yebra MT, Cuevas J, Contrer F. Syphilis in an HIV-positive patient misdiagnosed as leprosy. J Cutan Pathol 1999; 1: 51-54.
26. Goeman J, Kivuvu M, Nzila N, Behets F, Edidi B, Gnaore E, Van Dyck E, St Louis M, Piot P, Laga M. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 1995; 71: 275-279.
27. Goh BT, Smith GW, Samarasinghe L et al. Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without probenecid. Br J Vener Dis 1984; 60: 371-373.
28. Goldenberg R, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003; 189: 861-873.
29. Gordon SM, Eaton ME, George R, Larsen S, Lukehart SA, Kuypers J, Marra CM, Thompson S. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immuno-deficiency virus infection. N Engl J Med 1994; 331: 1469-1473.
30. Gruber F, Kastelan M, Cabrijan L, Simonic E, Brajac I. Treatment of early syphilis with azithromycin. J Chemother 2000; 12: 240-243.
31. Hagedorn HJ, Kraminer-Hagedorn A, Wiegel U. Prophylaxe und Diagnostik der Syphilis connata aus immunologischer Sicht. Dtsch Med Wschr 1983; 108: 142-145.
32. Hahn RD, Webster B, Weickhardt G et al. The results of treatment of 1086 general paralytics the majority of whom were followed up for more than 5 years. J Chron Dis 1958; 7: 209-227.
33. Hall CS, Klausner JD, Bolan GA. Managing syphilis in the HIV-infected patient. Curr Infect Dis Rep 2004; 6: 72-81.
34. Hamouda O, Marcus U. Syphilis auf dem Vormarsch. Hautarzt 2005; 56: 124-132.
35. Handrick W, Blatz R, Schroten H Lues connata, in: Deutsche Gesellschaft für pädiatrische Infektiologie (Hrsg.): Handbuch Infektionen bei Kindern und Jugendlichen. 4 Aufl. Futuramed Verlag München, S. 2003; 470-476.
36. Handrick W, Seemann U, Blatz R, Nietzschmann U. Lues connata. Eine retrospektive Analyse. Pädiat prax 2003; 63: 277-284.
37. Hook EW, Marra CM. Acquired syphilis in adults. N Engl J Med 1992; 326: 1060-1069.
38. Hook EW 3rd, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29: 486-490.
39. Hutchinson CM, Hook EW Syphilis in adults. Med Clin Norh Am 1990; 74: 1389-1416.
40. Idsoe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis: the experience of three decades. Bull World Health Org 1972; 47 (Suppl 1): 1-68.
41. Kent CK, Wolf W, Nieri G, Wong W, Klausner JD. Internet use and early syphilis infection among men who have sex with men: San Francisco, California, 1999-2003 MMWR Morb Mortal Wkly Rep 2003; 52: 1229-1232.
42. Kingston MA, Higgins SP. Audit of the management of early syphilis at North Manchester General Hospital Int J STD AIDS 2004; 15(5): 352-354.
43. Kingston MA, Higgins SP. Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals. Sex Transm Infec 2004; 80: 152-153.
44. Körber A, Dissemond J, Lehnen M, Franckson T, Grabbe S, Esser S. Syphilis bei HIV-Koinfektion JDDG 2004; 2: 833-840.
45. Koppermann M, Körber A, Grabbe S, Esser S. Diagnosis of neurosyphilis by cerebrospinal fluid in HIV-positive patients with primary or secondary infectious syphilis and CSF-repuncture after 12 months for therapy control after intravenous penicillin G treatment. The XV International AIDS Conference, Bangkok 2004, Abstract no. 2004; MoPeB3283.
46. Korting HC, Walther D, Riethmüller U et al. Comparative in vivo susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. Chemotherapy. 1986; 32: 352-355.
47. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995; 8: 1-21.
48. Luger A, Schmidt BL, Steyrer K, Schonwald E. Diagnosis of neurosyphilis: examination of cerebrospinal fluid. Br J Vener Dis 1981; 57: 232-237.
49. Lukehart SA, Godornes C, Molini BJ, Sonnett P, Hopkins S, Mulcahy F, Engelman J, Mitchell SJ, Rompalo AM, Marra CM, Klausner JD. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351: 154-158.
50. Lukehart SA, Hook EW, Baker-Zander SA et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis und treatment. Ann Intern Med 1988; 109: 855-862.
51. Malessa R, Agelink MW, Hengge U, Mertins L, Gastpar M, Brockmeyer NH. Oligosymptomatic neurosyphilis with false negative CSF-VDRL in HIV-infected individuals. Eur J Med Res 1996; 1: 299-302.
52. Mandelbrot L, Marcollet A. Syphilis au cours de la grossesse. Rev Prat 2004; 54: 392-395.
53. Marcus U, Kiehl W, Hamouda O. Zur aktuellen Entwicklung der Syphilis in Deutschland. Hautarzt 2003; 54: 1125-1130.
54. Marra CM, Boutin P, McArthur JC et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000; 30: 540-544.
55. Marra CM, Maxwell CL, Smith SL et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189: 369-376.
56. McBroom RL, Styles AR, Chiu MJ, Clegg C, Cockerell CJ, Radolf J. Secondary syphilis in persons infected with and not infected with HIV-1: a comparative immunhistologic study. Am J Dermatopathol 1999; 5: 432-441.
57. Michelow IC, Wendel GD, Norgard MV, Zeray F, Leos K, Alsaadi R, Sanchez PJ. Central nervous system infection in congenital syphilis. N Engl J Med 2002; 346: 1792-1798.
58. MIQ 16 Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik: Syphilis (erarbeitet von H.-J. Hagedorn). Urban & Fischer, München, Jena S 2001; 1-40.
59. Müller F, Hagedorn HJ. Syphilis. In: Thomas L (Hrsg) Labor und Diagnose. TH-Books, Frankfurt/Main, S 1998; 1232-1241.
60. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Int Med 1990; 113: 872-881.
61. Myint M, Baschiri H, Harrington RD, Marra CM. Relapse of secondary syphilis after benzathine penicillin G: molecular analysis. Sex Transm Dis 2004; 31: 196-199.
62. Nau R, Prange HW, Muth P et al. Passage of cefotaxime and ceftriaxone into the cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 1993; 27: 1518-1524.
63. Norgard MV, Miller JN. Plasmid DNA in Treponema pallidum : potential for antibiotic resistance by syphilis bacteria. Science 1981; 213: 535.
64. O'Mahony C, Rodgers CA, Mendelsohn SS, Sissons G, McKay A, Devine J, Keeping IM. Rapidly progressive syphilis in early HIV infection. Int J STD AIDS 1997; 8: 275-277.
65. Pao D, Goh BT, Bingham JS. Management issues in syphilis. Drugs 2002; 62: 1447-1461.
66. Parkes R, Renton A, Meheus A, Laukamm-Josten U. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 2004; 15: 73-88.
67. Paryani SG, Vaughn AJ, Crosby M, Lawrence S. Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. J Pediatr 1994; 125: 471-475.
68. Pehamberger H. [Single dose treatment of primary syphilis with Benzathine penicillin] Wien Med Wochenschr. 1981; 131: 213-215.
69. Potthoff A, Brockmeyer NH. Syphilis und HIV-Infektion Besonderheiten der Diagnose, Klinik und Therapie. Hautarzt 2005; 56: 133-140.
70. Prange H. Neurosyphilis Weinheim: VCH-Verlag, edition medizin 1987.
71. Prange H, Ritter G. Epidemiologie der Neurosyphilis. Nervenarzt 1981; 52: 32-35.
72. Prange H, Bobis-Seidenschwanz I. Zur Evaluierung serologischer Aktivitätskriterien bei Neurosyphilis. Verh.Dtsch. Ges.Neurol. 1994/95; 8: 789-791.
73. Prange H Neurosyphilis. In: Prange H (Hrsg) Infektionskrankheiten des ZNS. Chapman & Hill, London pp 1995; 237-250.
74. Quinn TC, Bender B Sexually transmitted diseases. In: Harvey AM, Johns RJ, McKusick VA et al. (Eds.) The Priciples and Practice of Medicine. 22nd ed. Norwalk, CT Appleton & Lange 1988; gg. 1-663.
75. RKI. Neurosyphilis - Fallbericht, Bedeutung, Diagnostik und Prävention. Epid Bull 2002; 5: 35-36.
76. RKI. Praktische Empfehlungen zur Serodiagnostik der Syphilis. Epid Bull 2003; 25: 191-192.
77. RKI. Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Berichtsmonat Dezember 2003. Epid Bull 2004; 10: 85.
78. RKI. Syphilis in Deutschland 2003. Interpretation der Meldedaten nach dem IfSG. Epid Bull 2004; 40: 339-343.
79. RKI. Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Berichtsmonat April 2004; 28: 223.
80. Rockwell DH, Yobs AR, Moore MB. The Tuskegee study of untreated syphilis. Arch Intern Med 1964; 114: 792-798.
81. Rolfs RT, Joesoef RM, Hendershot EF et al. A randomised trial of enhanced therapy for early syphilis in patients with and without HIV infection. N Engl J Med 1997; 337: 307-314.
82. Rompalo AM, Joesoef MR, O'Donnell JA, Augenbraun M, Brady W, Radolf JD, Johnson R, Rolfs RT Clinical manifestations of early syphilis by HIV-status and gender: results of the syphilis and HIV study. Sex Transm Dis 2001; 28: 158-165.
83. Rompalo AM, Lawlor J, Seaman P, Quinn TC, Zenilman JM, Hook, EW. Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 2001; 28: 448-454.
84. Schmid GP. Approach to the patient with genital ulcer disease. Med Clin North Am 1990; 74: 1559.
85. Schmidt BL, Edjlalipour M, Luger A. Comparative evaluation of nine different enzyme-linked immunosorbent assay for determination of antibodies against Treponema pallidum in patients with primary syphilis. J Clin Microbiol 2000; 38: 1279-1282.
86. Schöfer H, Imhof M, Thoma-Greber E et al. Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med 1996; 72: 176.
87. Schöfer H Syphilis. Klinische Aspekte der Treponema pallidum Infektion. Hautarzt 2004; 55: 112-119.
88. Schöfer H. Behandlung der Syphilis. Deutsche und internationale Leitlinien - ein Vergleich. Hautarzt 2005; 56:141-150.
89. Schrag S, Arnold K, Mohle-Boetani J, Lynfield, R, Zell E, Stefon K, Noga H, Craig A, Sanza T, Smith G, Schuchat A. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 2003; 102: 753-760.
90. Sellati TJ, Wilkinson DA, Sheffield JS, Koup RA, Radolf JD, Norgard MV. Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J Infect Dis 2000; 1: 283-293.
91. Serragui S, Yahyaoui M, Hassar M, Chkili T, Bouhaddioui N, Soulaymani R. A comparison study of two therapeutic protocols for neurosyphilis.Therapie 1999; 54: 613-621.
92. Singh AE, Romanowski B. Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12: 187-209.
93. Smith NH, Musher DM, Huang DB, Rodriguez PS, Dowell ME, Ace W, White AC. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicilline. Int J STD AIDS 2004; 15: 328-332.
94. Smith G, Holmann RP. The prozone phenomenon with syphilis and HIV co-infection. South Med J 2004; 97: 327-328.
95. Stapleton JT, Stamm LV, Bassford PJ. Potential for development of antibiotic resistance in pathogenic treponemes. Rev Infect Dis 1985; 7 (Suppl 2): S314-S317.
96. Todd G, Krause W. Sexually transmitted diseases, in: Pediatric Dermatology, Eds. RO Hansen and Schacher, 3rd Edition. Elsevier, New York, N.Y. 2003.
97. Vécsei AKW, Vécsei PV, Dangl-Erlach E, Gadner H. Lues connata: späte Diagnose trotz Screenings. Wien Klin Wochenschr 1999; 111: 410-413.
98. Zenker PN, Rolfs RT. Treatment of syphilis 1989. Rev Infect Dis 1990; 12 (Suppl 6): 591-609.